ABBOTT PARK, Ill., May 3, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™. Advisor HD Grid employs a new design that allows physicians to see things differently, capturing and analyzing data in a novel manner to create […]
Author: Ken Dropiewski
Intact Vascular Announces Enrollment Completion of the Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial
WAYNE, Pa.–(BUSINESS WIRE)– Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has completed enrollment. A total of 200 patients have been enrolled in TOBA III at 14 sites in Europe. The TOBA III study is a […]
HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a U.S.-based medical device company that is leading innovation in the field of electrocardiology through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced today that Peter W. Macfarlane has joined its board of clinical advisors. Professor Peter W. Macfarlane, DSc eFESC FRSE, […]
LivaNova Reports First Quarter 2018 Results
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2018. For the first quarter of 2018, worldwide sales from continuing operations were $250.4 million, an increase of 10.4 percent on a reported basis and an increase […]
CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–The fifth bullet in the Recent Highlights section should read: EPS of $0.11, Non-GAAP EPS of $0.07 (instead of EPS of $0.11, Non-GAAP EPS of $0.15). The correct figure of $0.07 is represented in the Second Quarter Fiscal 2018 Financial Results section and throughout the financial tables. […]
Nobles Medical Launches Sales of its NobleStitch™ EL for PFO Closure in Spain
BARCELONA, Spain, May 2, 2018 /PRNewswire/ — NMT2 announces the further expansion of the NobleStitch™ EL with the addition of Hospitals in Barcelona, the first to perform PFO closure cases in Spain has been Vall Hebron Hospital. Dr. Gerard Marti, Consultant in Interventional Cardiology and Structural Heart disease at the Hospital Vall Hebron was the first […]
New Study Examines Online Vs Offline ECG Monitoring to Detect Difficult-to-Diagnose Arrhythmia
BOSTON, May 2, 2018 /PRNewswire/ — Medicalgorithmics, S.A. (WSE: MDG) today announced the presentation of a large study evaluating online vs offline ECG monitoring methods to diagnose paroxysmal atrial fibrillation (AF), often difficult to detect because of its episodic nature. Research will be presented at the Heart Rhythm Society Annual Scientific Sessions, May 9-12 at […]
Abbott’s XIENCE Sierra™ Heart Stent Receives National Reimbursement in Japan to Treat People with Coronary Artery Disease
ABBOTT PARK, Ill., May 2, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced that Japan’s Ministry of Health Labour and Welfare (MHLW) granted national reimbursement for XIENCE Sierra™, the newest generation of the company’s gold-standard XIENCE everolimus-eluting coronary stent. XIENCE Sierra improves upon previous versions of XIENCE with an enhanced stent design, a new delivery […]
iSchemaView Receives FDA Clearance for RAPID CTA Leader in Advanced Cerebrovascular Imaging First to Meet the Needs of Large and Small Centers and Hospitals with New CTA Support and 3D Imaging Added to Complete Suite of RAPID Offerings
Menlo Park, Calif. – May 1, 2018 – iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final clearance from the U.S. Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography Angiography. RAPID CTA is the newest addition to iSchemaView’s industry […]
Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration Developed at IU School of Medicine
INDIANAPOLIS, May 1, 2018 /PRNewswire/ — Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to disease […]



